Recombinant Streptococcus pyogenes Cas9 Protein, N-His

Description of Recombinant Streptococcus pyogenes Cas9 Protein, N-His

Recombinant Streptococcus pyogenes Cas9 protein is a highly versatile and powerful tool in the field of molecular biology and genetic engineering. It is a type II CRISPR-associated endonuclease enzyme that is derived from the bacterium Streptococcus pyogenes. This protein has gained widespread attention and use due to its ability to precisely target and edit specific sequences of DNA. In this article, we will discuss the structure, activity, and applications of Recombinant Streptococcus pyogenes Cas9 protein.

The recombinant Streptococcus pyogenes Cas9 protein is composed of 1,368 amino acids and has a molecular weight of approximately 160 kDa. It consists of two functional domains, the HNH domain and the RuvC-like domain, which are responsible for the protein’s endonuclease activity. The HNH domain is responsible for cleaving the DNA strand that is complementary to the guide RNA, while the RuvC-like domain cleaves the non-complementary DNA strand.

The Cas9 protein also contains a PAM (protospacer adjacent motif) recognition domain that is responsible for identifying the specific DNA sequence to be targeted. This sequence is known as the PAM sequence and is essential for the Cas9 protein to bind and initiate the DNA cleavage process.

The activity of recombinant Streptococcus pyogenes Cas9 protein is dependent on its ability to bind to the target DNA sequence and form a complex with the guide RNA. The guide RNA contains a complementary sequence to the target DNA and directs the Cas9 protein to the specific location for DNA cleavage. Once the Cas9 protein is bound to the target DNA, it induces a double-stranded break at the PAM sequence, resulting in the formation of blunt ends.

The Cas9 protein has also been engineered to have a catalytically inactive form, known as dCas9, which can still bind to the target DNA but does not induce a double-stranded break. This form of Cas9 is often used for gene regulation and transcriptional activation or repression.

The recombinant Streptococcus pyogenes Cas9 protein has revolutionized the field of genetic engineering and has a wide range of applications. One of its most significant uses is in genome editing, where it can be used to precisely target and modify specific DNA sequences. This has immense potential in gene therapy, disease modeling, and drug discovery.

Cas9 protein has also been used for gene regulation and has been successfully used to activate or repress gene expression in various cell types. This has opened up new avenues for studying gene function and understanding complex biological processes.

Moreover, the Cas9 protein has also been used in diagnostics, where it can be used to detect the presence of specific DNA sequences in a sample. This has potential applications in the detection of infectious diseases and genetic disorders.

In addition to its applications in research, the Cas9 protein also has potential therapeutic uses. It has been used in clinical trials for the treatment of genetic disorders such as sickle cell disease and beta-thalassemia. The ability of Cas9 to precisely target and edit specific DNA sequences holds promise for the development of personalized medicine.

In conclusion, recombinant Streptococcus pyogenes Cas9 protein is a powerful and versatile tool in the field of molecular biology and genetic engineering. Its precise targeting and editing capabilities have revolutionized the way we study and manipulate DNA. With ongoing research and advancements in this field, the potential applications of Cas9 protein are endless, and it will continue to play a crucial role in shaping the future